Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Operating Leases (2019 - 2020)

Historic Operating Leases for Larimar Therapeutics (LRMR) over the last 2 years, with Q3 2020 value amounting to $6.1 million.

  • Larimar Therapeutics' Operating Leases fell 559.83% to $6.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $6.1 million, marking a year-over-year decrease of 559.83%. This contributed to the annual value of $6.5 million for FY2019, which is N/A changed from last year.
  • Larimar Therapeutics' Operating Leases amounted to $6.1 million in Q3 2020, which was down 559.83% from $6.3 million recorded in Q2 2020.
  • Larimar Therapeutics' 5-year Operating Leases high stood at $6.5 million for Q3 2019, and its period low was $567000.0 during Q1 2019.